OM logo

OMOutset Medical Inc

$4.62
$0.07
(1.49%)
Today
Closed $4.62
$0.00
(0.00%)
After Hours
Updated: 07:40 PM EDT
EarningsAug 5
Mkt Cap$86.84M
Vol180,183.00
News
all
press releases
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, June 5, 2026 Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be...
PR Newswire
News Placeholder
More News
News Placeholder
DaVita Expands Comprehensive Kidney Care Through Dialysis Services
DVA expands kidney-care reach with integrated CKD/ESKD coordination and 2026 AI scheduling tech to boost dialysis efficiency.
Zacks
News Placeholder
DaVita Gains 21.4% in Three Months: How Should You Play the Stock?
DVA raises guidance on stronger dialysis volumes and reimbursement gains, but rising patient-care and technology costs could squeeze margins.
Zacks
News Placeholder
Outset Medical (OM) Q4 2025 Earnings Transcript
Outset Medical (OM) Q4 2025 Earnings Transcript...
Yahoo! Finance: News
News Placeholder
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Outset Medical (OM) delivered earnings and revenue surprises of -5.06% and -3.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Outset Medical (OM) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
News Placeholder
BML Capital Management LLC Makes New $2.02 Million Investment in Outset Medical, Inc. $OM
BML Capital Management LLC purchased a new position in shares of Outset Medical, Inc. (NASDAQ:OM - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 543,180 shares of the company's sto...
MarketBeat
News Placeholder
Outset Medical, Inc. (NASDAQ:OM) Given Average Rating of "Moderate Buy" by Analysts
Outset Medical, Inc. (NASDAQ:OM - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the five ratings firms that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating...
MarketBeat
News Placeholder
Outset Medical (OM) to Release Quarterly Earnings on Wednesday
Outset Medical (NASDAQ:OM) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-outset-medical-inc-stock...
MarketBeat
News Placeholder
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, April 13, 2026...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.